Shape-HF’s Clinical Advantage

Dyspnea is complex. It arises from a variety of pathophysiologies that each contribute to the degree of functional impairment and patient risk. Standard, largely subjective methods for defining patient functional status, evaluating response to therapy, and assessing risk do not adequately define – or even point to – contributing pathophysiology.

Shape-HF opens a window to patient physiology, helping physicians make informed decisions on patient status, diagnosis and therapy options. Doctors may monitor patient progress over time, adjust therapy and track the response. And, Shape-HF can let physicians see the impact of therapy decisions often before an overt change in patient symptoms.

In patients with pacemakers or in cardiac resynchronization therapy, Shape-HF helps assess rate response and can be used to optimize CRT while the patient is upright and exercising to a level consistent with the activities of daily living.

In using the Shape-HF system, physicians gain new and important information to better assess patient functional status, therapy response, exercise-induced changes, primary source of limitation, and patient risk.

Shape-HF makes cardiopulmonary exercise testing available for widespread use in clinical settings including hospitals, primary care settings as well as specialist clinics such as cardiology, pulmonology, pulmonary hypertension, internal medicine, and sleep clinics.

“Shape-HF allows us to easily evaluate the patient, diagnose the problem and its severity, and conduct follow up tests to measure the response to treatment. No other test is equivalent.”

Dr. Syed I. Mobin M.D. FCCP, FAASM, Central Florida Pulmonary Group